BE728658A - - Google Patents

Info

Publication number
BE728658A
BE728658A BE728658DA BE728658A BE 728658 A BE728658 A BE 728658A BE 728658D A BE728658D A BE 728658DA BE 728658 A BE728658 A BE 728658A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE728658A publication Critical patent/BE728658A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
BE728658D 1968-03-06 1969-02-19 BE728658A (US06589383-20030708-C00041.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB00906/68A GB1203691A (en) 1968-03-06 1968-03-06 New disubstituted n-amino indoline derivatives and process for preparing them

Publications (1)

Publication Number Publication Date
BE728658A true BE728658A (US06589383-20030708-C00041.png) 1969-08-19

Family

ID=9976474

Family Applications (1)

Application Number Title Priority Date Filing Date
BE728658D BE728658A (US06589383-20030708-C00041.png) 1968-03-06 1969-02-19

Country Status (13)

Country Link
US (1) US3565911A (US06589383-20030708-C00041.png)
BE (1) BE728658A (US06589383-20030708-C00041.png)
CH (1) CH507940A (US06589383-20030708-C00041.png)
DE (1) DE1909180A1 (US06589383-20030708-C00041.png)
DK (1) DK126193B (US06589383-20030708-C00041.png)
ES (1) ES364421A1 (US06589383-20030708-C00041.png)
FI (1) FI50119C (US06589383-20030708-C00041.png)
FR (1) FR2003311A1 (US06589383-20030708-C00041.png)
GB (1) GB1203691A (US06589383-20030708-C00041.png)
IT (1) IT8049196A0 (US06589383-20030708-C00041.png)
NL (1) NL145226B (US06589383-20030708-C00041.png)
NO (1) NO128068B (US06589383-20030708-C00041.png)
SE (1) SE334887B (US06589383-20030708-C00041.png)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4112111A (en) * 1975-02-26 1978-09-05 Sandoz Ltd. Indolinylguanidines
IT1113879B (it) * 1979-03-15 1986-01-27 Farmatis Spa Derivato isoindolinico,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo
LU82949A1 (fr) * 1980-11-20 1981-06-04 Usv Pharma Corp Nouveaux amino-benzamides,leur procede de preparation et leur application au traitement de l'hypertension
EP0054892B1 (en) * 1980-12-22 1985-09-18 SCIENCE UNION ET Cie Synthesis of indolines
JPS57206657A (en) * 1981-06-16 1982-12-18 Mitsui Toatsu Chem Inc Sulfamoylbenzoic acid derivative and remedying composition containing said derivative as active component
FR2529785A1 (fr) * 1982-07-09 1984-01-13 Adir Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne
FR2663325B1 (fr) * 1990-06-14 1992-09-04 Adir Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide a partir de la 2,3-dihydro 2-methyl 1h-indole et de l'acide hydroxylamine-o-sulfonique.
FR2663324B1 (fr) * 1990-06-14 1992-09-04 Adir Nouveau procede de preparation industrielle du 4-chloro 3-sulfamoyl n-(2,3-dihydro 2-methyl 1h-indol-1-yl) benzamide.
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5319096A (en) * 1992-04-03 1994-06-07 Hoechst-Roussel Pharmaceuticals Inc. (1H-indol-1-yl)-2-(amino) acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides, pharmaceutical composition and use
IT1288123B1 (it) * 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
EP1545519B1 (en) 2002-08-19 2011-03-23 Pfizer Inc. Combination therapy for hyperproliferative diseases
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
JP2008520578A (ja) * 2004-11-15 2008-06-19 ニトロメッド インコーポレーティッド 複素環式の酸化窒素供与体基を含む利尿化合物、組成物および使用方法
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのcetp阻害剤としてのn−((3−ベンジル)−2,2−(ビス−フェニル)−プロパン−1−アミン誘導体
FR2924713B1 (fr) * 2007-12-11 2010-01-29 Servier Lab Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2575808A1 (en) 2010-05-28 2013-04-10 Mahmut Bilgic Combination of antihypertensive agents
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JOP20210193A1 (ar) 2019-01-18 2023-01-30 Astrazeneca Ab مثبطات pcsk9 وطرق استخدامها
WO2023001880A1 (en) 2021-07-22 2023-01-26 Krka, D. D., Novo Mesto Bilayer tablet comprising telmisartan and indapamide
EP4295839A1 (en) 2022-06-20 2023-12-27 KRKA, d.d., Novo mesto Combination of valsartan and indapamide
EP4374855A1 (en) 2022-11-22 2024-05-29 KRKA, D.D., Novo Mesto Pharmaceutical dosage form of candesartan and indapamide

Also Published As

Publication number Publication date
FR2003311A1 (US06589383-20030708-C00041.png) 1969-11-07
NL145226B (nl) 1975-03-17
DK126193B (da) 1973-06-18
SE334887B (US06589383-20030708-C00041.png) 1971-05-10
IT8049196A0 (it) 1980-07-09
FI50119C (fi) 1975-12-10
US3565911A (en) 1971-02-23
CH507940A (fr) 1971-05-31
FI50119B (US06589383-20030708-C00041.png) 1975-09-01
NL6903421A (US06589383-20030708-C00041.png) 1969-09-09
DE1909180A1 (de) 1970-07-02
NO128068B (US06589383-20030708-C00041.png) 1973-09-24
GB1203691A (en) 1970-09-03
ES364421A1 (es) 1971-02-01

Similar Documents

Publication Publication Date Title
AU1946070A (US06589383-20030708-C00041.png)
AU428130B2 (US06589383-20030708-C00041.png)
AU2374870A (US06589383-20030708-C00041.png)
AU5184069A (US06589383-20030708-C00041.png)
AU429879B2 (US06589383-20030708-C00041.png)
AU4304568A (US06589383-20030708-C00041.png)
AU2581067A (US06589383-20030708-C00041.png)
AU4811568A (US06589383-20030708-C00041.png)
AU421558B1 (US06589383-20030708-C00041.png)
AU4744468A (US06589383-20030708-C00041.png)
AR203075Q (US06589383-20030708-C00041.png)
AU3224368A (US06589383-20030708-C00041.png)
AU3789668A (US06589383-20030708-C00041.png)
AU2580267A (US06589383-20030708-C00041.png)
AU4224469A (US06589383-20030708-C00041.png)
AU3083868A (US06589383-20030708-C00041.png)
AU2496167A (US06589383-20030708-C00041.png)
BE728395A (US06589383-20030708-C00041.png)
SE334887B (US06589383-20030708-C00041.png)
BE709435A (US06589383-20030708-C00041.png)
BE709415A (US06589383-20030708-C00041.png)
BE709320A (US06589383-20030708-C00041.png)
BE727938A (US06589383-20030708-C00041.png)
BE728219A (US06589383-20030708-C00041.png)
BE709319A (US06589383-20030708-C00041.png)

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: SOC FRANCAISE DE RECHERCHE MEDICALE

Effective date: 19890219

Owner name: SCIENCE UNION & CIE

Effective date: 19890219